Transient MR changes and symptomatic epilepsy following gamma knife treatment of a residual GH-secreting pituitary adenoma in the cavernous sinus by Schindler, K et al.
Acta Neurochir (Wien) (2006) 148: 903–908
DOI 10.1007/s00701-006-0796-3
Case Report
Transient MR changes and symptomatic epilepsy
following gamma knife treatment of a residual GH-secreting
pituitary adenoma in the cavernous sinus
K. Schindler1, E. R. Christ2, T. Mindermann3, and H. G. Wieser1
1 Department of Epileptology and EEG, University Hospital Z€urich, Z€urich, Switzerland
2 Department of Endocrinology, Inselspital Bern, Bern, Switzerland
3 Gamma Knife Center Z€urich, Klinik Im Park, Z€urich, Switzerland
Received November 24, 2005; accepted April 18, 2006; published online June 19, 2006
# Springer-Verlag 2006
Summary
Objective. To report a rare side effect of gamma knife treatment of
pituitary macroadenoma.
Case report. In a forty-one-year old female patient acromegaly was
diagnosed due to a growth hormone secreting pituitary macroadenoma.
Following transsphenoidal surgery the patient underwent gamma knife
treatment for persistent uncontrolled acromegaly activity of residual
tumor, infiltrating the left cavernous sinus. 15 months later, complex
partial seizures were diagnosed and 17 months after gamma knife treat-
ment a gadolinium enhancing lesion was detected in her left medial
temporal lobe. Radiation induced changes, radiation necrosis or a glioma
were considered. Neuropsychological testing indicated potentially sig-
nificant post-surgical deficits. Therefore, surgical action was postponed
and anti-epileptic treatment was started. Four months later she was free
of seizures and an MR scan showed an almost complete regression of the
gadolinium enhancing lesion, indicating that it had been due to radiation
induced changes.
Conclusion. Gamma knife surgery of a pituitary adenoma may
cause radiation induced MR changes of the mesial temporal lobe
mimicking glioma or radionecrosis and cause symptomatic epileptic
seizures. The awareness of this rare complication is important to
avoid unnecessary and potentially harmful diagnostic or therapeutic
interventions.
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Introduction
Acromegaly is a rare but serious disorder due to a growth
hormone (GH)-producing pituitary adenoma. Retrospec-
tive studies indicate that mortality is approximately dou-
bled relative to the general population, mostly due to
cardiovascular events [1–3].
Patients with epilepsy suffer from diminished quality
of life and have a mortality rate, which has been esti-
mated to be 2–3 times higher compared with the general
population [4] and similar to acromegalic patients.
Specifically, mortality has been shown to be positively
correlated with seizure rate [5]. Therefore, the aim of
treatment of patients with epilepsy is to render them
seizure free, which is achieved in approximately two
thirds by antiepileptic drugs. However, in certain epilepsy
syndromes, and in particular in patients with mesial
temporal lobe epilepsy (MTLE) pharmaco-resistance is
frequent [6]. If additional investigations localize the
epileptogenic zone to a brain area that can be removed
without serious neurological deficits, surgical treatment
should be considered [7]. Patients with temporal lobe
epilepsy have been shown to become free of disabling
seizures in approximately two thirds following selective
amygdalohippocampectomy [8]. Recent evidence sug-
gests that gamma knife surgery can be a therapeutic tool
for uncontrolled growth hormone secreting pituitary ad-
enoma and for mesial temporal lobe epilepsy [9, 10].
Radiation induced MR changes outside the radiosurgical
target and associated transient increase of seizure rate are
well-known side effects of gamma knife radiosurgery for
temporal lobe epilepsy. However, these complications
have not been reported in larger series of gamma knife
treatments for pituitary adenoma [11–13]. In this case
report, we present a patient who suffered from delayed
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radiation induced MR changes of the mesial temporal
lobe and transient symptomatic complex partial seizures
following gamma knife radiosurgery of residual pitui-
tary adenoma mimicking a glioma on MR scans.
Case report
The patient is a 41-year-old right-handed female, who signed in-
formed consent allowing us to report the results of her clinical investiga-
tions for scientific publication.
In 1999 the patient realized that her fingers and feet were growing and
she had to buy new shoes every six months. At the beginning of 2002
symptomatic right-sided carpal tunnel syndrome was diagnosed and
treated conservatively. She started to suffer from a new kind of retro-
orbital headache and was often sweating excessively. In addition, the
upper part of her visual fields started to become constricted. Chronic
fatigue and snoring was reported and sleep apnea syndrome was suspected.
The pneumologist suspected a growth hormone (GH) secreting tumor
and referred the patient for endocrinological assessment. Symptoms and
signs of acromegaly were recorded and biochemical investigation con-
firmed a GH-secreting tumor. Perimetry confirmed slightly constricted
visual fields bilaterally in the upper nasal quadrants. MR imaging de-
monstrated a pituitary macroadenoma, which slightly compressed the
optic chiasm and infiltrated the left cavernous sinus. Transseptal and
transsphenoidal surgery was performed. Histologically the tumor stained
mainly for GH with a relatively high proliferation activity (MIB-1-
labelling index >3%). Although clinical symptoms and signs of acro-
megaly improved, biochemical assessment revealed persistent signs and
symptoms of acromegaly and MR imaging showed residual tumor in the
left cavernous sinus within a distance of approximately 6–7 mm to the
optic nerve. In May 2003 the patient underwent gamma knife treatment
for the residual adenoma, which was performed by one of us (TM).
At the time of gamma knife treatment, the residual adenoma had a
tumor volume of 1.5 ccm (Fig. 1). On the day of the treatment, a Leksell
stereotactic frame was attached to the patient’s head under local anaes-
thesia and a stereotactic CT scan and MRI were obtained. MRI distor-
tions were corrected for with the CT scan. The tumor was treated with a
prescription dose of 30 Gy at the 50% isodose and the tumor margin and
a reference dose of 60 Gy to the target center (Fig. 2). The treatment was
performed with 7 isocenters of which 6 had a diameter of 8 mm and 1 of
4 mm. The 8 mm collimators had 82 plugs for each shot and the 4 mm
collimator had 14 plugs. The target volume was 1.5 ccm, the overall
volume of the 10 Gy isodose was 15.1 ccm. Of the mesial temporal lobe,
3.9 ccm were exposed to 10 Gy and 0.17 ccm to 24 Gy.
The treatment course was uneventful and the patient was discharged
home the same day. In the following days, starting on the next day, the
patient began to experience up to 30 paroxysmal and stereotypical
attacks per week consisting of repetitive twitching of the right corner
of her mouth and her right arm without impaired consciousness. Focal
motor seizures were suspected. A MR scan in July 2003 did not reveal
any new pathological findings (Fig. 3) and antiepileptic treatment was
not initiated because seizure rate subsequently had decreased to one
every other week. Biochemically, IGF-I levels decreased but remained
slightly above normal range and, therefore, Sandostatin LAR 10 mg
Fig. 2. MR scan showing the treatment plan for gamma knife radio-
surgery. The optic chiasm is outlined in blue, the adenoma in red, the
50% isodose in yellow and the 16% isodose in green. The yellow 50%
isodose represents the 30 Gy isodose and the green 16% isodose re-
presents the 10 Gy isodose
Fig. 1. MR (T1-weighted) scan showing the residual hypophyseal
adenoma before gamma knife surgery. The adenoma infiltrates the left
cavernous sinus (arrow). The volume of the adenoma was computed to
be 1.5 ccm
Fig. 3. An MR (FLAIR) scan four months after gamma knife surgery
shows the residual hypophyseal adenoma, but no new pathological lesions
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every three weeks was initiated with normalization of IGF-I levels. At
this time the focal motor seizures ceased. However, in August 2004 a
new kind of paroxysmal attacks occurred characterized by ‘a peculiar
and rather unpleasant sensation’ in the patient’s head, which was fol-
lowed by a ‘strange feeling of familiarity’, evolving into impairment of
consciousness. Postictally the patient was extremely tired for several
hours and suffered from speech problems, which only slowly resolved.
These attacks could occur up to eight times per day. MR imaging in
October 2004 revealed a space occupying lesion in the medial left tem-
poral lobe, which showed central enhancement in the uncus and in the
parahippocampal gyrus (Fig. 4). The paroxysmal attacks were diagnosed
as symptomatic complex partial seizures. EEG showed intermittent
slowing over the left fronto-temporal region but no epileptiform activity.
Carbamazepine was started but seizure rate continued to increase.
The differential diagnosis basically consisted of a new brain tumor,
primarily a glioma or radio-surgery induced changes or necrosis. An ir-
radiation induced neoplasia seemed unlikely given the short time peri-
od following irradiation [14]. Surgical exploration was recommended.
However, the patient asked for a second opinion and was transferred to
our hospital in November 2004. MR scans were repeated and showed
progression of the lesion in the temporal lobe, which appeared centrally
necrotic (Fig. 5). A 2-[18F]-2-deoxy-D-glucose (FDG)-PET of the brain
Fig. 4. MR scans 19 months after gamma knife surgery. The T2-weighted image in 3A shows a diffuse signal hyperintensity in the left medial
temporal lobe. This lesion enhances after gadolinium as displayed in 3B. The primary differential diagnosis was between low-grade glioma and
radiation induced changes or necrosis
Fig. 5. Gadolinium enhancement in the left medial temporal lobe was slightly progressive 20 months after gamma knife surgery as shown (arrows)
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is displayed in Fig. 6 and did not show any significant regions of asym-
metric hypometabolism. Magnetic resonance spectroscopy (MRS) was
performed and demonstrated increased N-acetylaspartate- (NAA-) and
choline peaks in the pathologically altered lesion compared to normally
appearing brain tissue. No lipids were detected in the lesion by MRS.
These findings were considered to support the diagnosis of a glioma.
Fig. 6. 18F-FDG-PET 20 months after gamma knife surgery scan detected no significant asymmetries and specifically no regions of asymmetrical
hypometabolism in the temporal lobes as would be typical for radio necrosis. Low metabolism is coded by dark blue to black colors as indicated by
the color bar on the left
Fig. 7. MR scan 25 months after gamma knife surgery. The T2-weighted image in A shows a regressive lesion in the left medial temporal lobe with
only minimal remaining signal hyperintensity (arrow). The T1 weighted image in B reveals no structural changes in the left temporal lobe. The
residual hypophyseal adenoma is reduced in size compared to earlier imaging studies
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Further pre-surgical evaluation was performed using a selective
Wada-test with inactivation of the territory of the A. choroidea anterior
on the left side [15]. The neuropsychological results indicated high
probability for impairment of memory and language deficits after surgi-
cal removal of the lesion. It was, therefore, decided to postpone surgical
procedures. In January 2005 the epileptic seizures ceased under continu-
ing medication with carbamazepine. A MR scan was repeated in April
2005 and revealed a significant regression of the lesion in the temporal
lobe (Fig. 7). On the follow-up visit in July 2005, the patient had
remained seizure-free. In August 2005, IGF-1 and oral glucose suppres-
sion test were within normal limits without octreotide medication. Two
years and three months after gamma knife radiosurgery, the acromegaly
was controlled.
Discussion
We present the case of a successful treatment of acro-
megaly resulting from residual parasellar GH-secreting
pituitary adenoma in the left cavernous sinus with gamma
knife radiosurgery. As a side effect of the treatment, the
patient however developed transient radiation induced
MR changes of the adjacent left mesial temporal lobe
with transient complex partial seizures. In order to treat
patients with pharmaco-resistant temporal lobe epilepsy,
Regis et al. [10] used the Leksell gamma knife in 21 pa-
tients. They targeted the mesial temporal lobe structures
such as the anterior parahippocampal cortex, the basal
and lateral part of the amygdala and the anterior hippo-
campus with a prescription dose of 24  1 Gy at the 50%
isodose and the target’s margin and a reference dose of
48 Gy. The target volume in radiosurgery for amygdalo-
hippocampectomy typically ranges from 5–8 ccm, which
means that 5–8 ccm of mesial temporal lobe tissue are ex-
posed to 24 Gy. Accordingly, during surgical amygda-
lohippocampectomy typically 8 ccm of mesial temporal
lobe tissue are removed. In comparison, in our patient
0.17 ccm of the left mesial temporal lobe received
24 Gy during gamma knife radiosurgery and 3.9 ccm of
the mesial temoral lobe were exposed to 10 Gy. In the
patient group of Regis et al., the peak of MR changes ap-
peared in the mesial temporal lobe with a median delay
of 13 months after gamma knife treatment (mean: 15;
range 8–21 months). The median duration of this peak
was 53 days (mean: 55; range 31–111 days) and 62% of
the patients were prescribed corticosteroids during this
time. In our case, the first significant MR changes were
detected 17 months after gamma knife treatment and
were seen to be clearly regressive on follow-up MR scan
6 months later, in keeping with the observations of Regis
et al. [10]. Importantly, in some patients with temporal
lobe epilepsy radiosurgery resulted in a transitory increase
in seizure rate and improvement of the seizure condition
occurred between 12–18 months following gamma knife
therapy. In the 21 patients reported by Regis et al. [10]
the average number of seizures per month decreased
from 10.1 pre-operatively to 7.3 one week later, but re-
increased to 9.3 on follow up visit I (6 months) before it
started to continuously drop and finally reach 1.5 after
2 years. In our patient the complex-partial seizures typi-
cal of medial temporal lobe onset started 15 months
following gamma knife surgery and were controlled ap-
proximately four months later by carbamazepine. This
time course may be explained by the fact that radio-
induced changes occurred in brain parenchyma that was
not epileptogenic before treatment as compared to the
patients of Regis et al. [10]. Thus, the epileptogenic
changes had first to take place, which may explain the
slightly delayed seizure onset. Furthermore, the primary
target of radiotherapy in our patient was not the tempo-
ral lobe but the residual adenoma, which infiltrated the
left cavernous sinus.
MR scan, FDG-PET and MRS were consistent with
the diagnosis of a glioma. Though there are reports of
spontaneous regression of low-grade astrocytoma [16]
especially in patients suffering from neurofibromatosis
type 1, spontaneous regression of malignant glioma was
only reported after subarachnoid hemorrhage thereby in-
ducing vasospasm and probably compromising the blood
supply of the tumor [17]. The regression of the malig-
nant glioma was only temporary and the patient even-
tually died a few years later. In the present case, the
patient was not known for neurofibromatosis and subar-
achnoidal haemorrhage was never detected favoring the
diagnosis of radiation induced changes in the temporal
lobe. It is intriguing that the FDG- PET scan did not de-
tect localized hypometabolism in the left temporal lobe
as would be typical for radiation induced necrosis [18].
One theoretically possible explanation for these PET
findings could be that there was intensive though still
subclinical epileptogenic activity taking place at the time
of the PET scan, which compensated for any existing ra-
diation induced hypometabolism in this region. Further-
more, the MR spectroscopy detected an increased NAA
peak relative to the contralateral side [19] pointing to an
increased cellular density as often observed in gliomas.
Whether radiation induced inflammation might explain
these MRS findings remains speculative, too.
To our knowledge, we report the first case of radia-
tion induced changes of mesial temporal lobe structures
and transient symptomatic epileptic seizures as a rare
side-effect of gamma knife radiosurgery of a pituitary
adenoma. Radiosurgery induced changes may mimic ma-
lignant glioma and the knowledge of the typical clinical
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course of radiation induced temporal lobe changes is
very important to prevent potentially harmful diagnostic
and therapeutic interventions. It is therefore important
that a neurosurgeon who performs radiosurgery is in-
volved in the follow-up of the patient. The question
arises if an alternative radiosurgical treatment e.g. with
a dedicated multimicroleaf collimator linear accelerator
(LINAC) may be less probable to lead to this side effect.
This is unlikely since the radiation dose to brain tissue
outside the target volume is significantly higher in the
treatment of skull base tumors with the LINAC than with
the gamma knife [20].
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Comment
This is an interesting and well-written report regarding a rare com-
plication of gamma knife surgery. The case they present had residual
tumour invading the cavernous sinus. High dose radiation, required to
achieve endocrine control, resulted in transient radiological changes in
the mesial temporal structures, associated with seizures.
This paper raises a few important issues. First, it is of note that such
complication can arise, despite the high precision of radiosurgery. If
high doses have to be used, the penumbra may be exposed to sufficient
radiation dose to cause untoward changes. In this case the dose applied
was indeed near the upper limit of what one would use and perhaps for
such a large tumour this may not be the level used in other centres. It is
true to say however that in order to ensure endocrine control it is not
unusual to use 30 Gy peripheral dose. Size of the tumour was important
in this case also because it resulted in a kind of dose plan which avoided
the optic pathways but the maneuvers necessary for this resulted in
higher dose within the temporal lobe than usual.
Second, the authors rightly indicated that the changes were temporary.
It is indeed the experience with many radiologically frightening MR
changes, that they resolve in a predictable timeframe. This is particularly
important when the treatment was delivered for benign conditions, for
instance for the treatment of mesial temporal sclerosis. Anxiety during
the period when these changes are prominent leads to investigations, at
times even biopsy or resection. Noninvasive investigation, like the MR
spectroscopy in this case, may be misleading, suggesting a glioma, and it
may be at times difficult to resist surgical intervention. In this case it was
only the Wada test, suggesting high risk after resection, that prevented
this happening.
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